Napnopen Tablet, 10 Tablets
Ilhwa Co., Ltd.
(주)일화Napnopen Tablet, 10 Tablets What it is used for
This medicine is used for rheumatoid arthritis, osteoarthritis (degenerative joint disease), ankylosing spondylitis, tendinitis, acute gout, dysmenorrhea, synovial (lubricating) bursitis, musculoskeletal disorders (sprains, bruises, wounds, low back pain), postoperative pain, migraine, and pain after tooth extraction.
Show the Korean original
이 약은 류마티양 관절염, 골관절염(퇴행성 관절질환), 강직성 척추염, 건염(힘줄염), 급성통풍, 월경곤란증과 활액(윤활)낭염, 골격근장애(삠, 타박상, 상처, 허리통증), 수술 후 통증, 편두통, 발치 후 통증에 사용합니다.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Napnopen Tablet, 10 Tablets How to take it
For rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis, adults should take 1-2 tablets (275-550 mg) per dose, 2 times a day every 12 hours. For acute gout, adults should take 3 tablets (825 mg) as the initial dose, then take 1 tablet (275 mg) at 8-hour intervals until the attack disappears. For musculoskeletal disorders, postoperative pain, pain after tooth extraction, dysmenorrhea, tendinitis, and synovial (lubricating) bursitis, adults should take 2 tablets (550 mg) as the initial dose, then administer 1 tablet (275 mg) at 6-8-hour intervals. The total daily dose should not exceed 5 tablets (1,375 mg). For migraine, adults should take 3 tablets (825 mg) as the initial dose. If necessary, 1-2 more tablets (275-550 mg) per day may be taken, and should be taken 30 minutes after the initial dose. The total daily dose should not exceed 5 tablets (1,375 mg). The dose may be appropriately increased or decreased according to age and symptoms.
Show the Korean original
류마티양 관절염, 골관절염, 강직성 척추염에 성인은 1회 1~2정(275~550 mg)씩, 1일 2회 12시간마다 복용합니다. 급성통풍에 성인은 처음 복용량으로 3정(825 mg)을 복용하고, 발작이 없어질 때까지 8시간 간격으로 1정(275 mg)을 복용합니다. 골격근장애, 수술후 통증, 발치 후 통증, 월경곤란증, 힘줄염, 활액(윤활)낭염에 성인은 처음 복용량으로 2정(550 mg)을 복용하고 6~8시간 간격으로 1정(275 mg)씩 투여합니다. 1일 총용량은 5정(1,375 mg)을 초과하지 않도록 합니다. 편두통에 성인은 처음 복용량으로 3정(825 mg)을 복용합니다. 필요하면 1일 1~2정(275~550 mg)을 더 복용할 수 있으며 처음 복용량의 복용 30분 후에 복용합니다. 1일 총용량은 5정(1,375 mg)을 초과하지 않도록 합니다. 연령, 증상에 따라 적절히 증감할 수 있습니다.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Napnopen Tablet, 10 Tablets Important warnings
If a person who regularly drinks 3 or more glasses of alcohol every day takes this medicine or another antipyretic analgesic, consult a doctor or pharmacist. It may cause gastrointestinal bleeding. Taking this medicine increases the risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which may be fatal, and serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulceration, and perforation may occur.
Show the Korean original
매일 세잔 이상 정기적 음주자가 이 약 또는 다른 해열진통제를 복용할 때는 의사 또는 약사와 상의하십시오. 위장출혈을 일으킬 수 있습니다. 이 약 복용 시 치명적일 수 있는 중대한 심혈관계 혈전 반응, 심근경색증, 뇌졸중의 위험이 증가하며, 위장관 출혈, 궤양 및 천공 등 심각한 위장관계 이상반응이 나타날 수 있습니다.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Napnopen Tablet, 10 Tablets Precautions
Do not take this medicine if you have hypersensitivity to this medicine, peptic ulcer, severe blood abnormalities, severe hepatic impairment, severe cardiac insufficiency, severe renal impairment, severe hypertension, or hypersensitivity to nonsteroidal anti-inflammatory analgesics such as aspirin; if you have asthma, rhinitis, nasal polyps, urticaria, allergic reactions, or a history thereof caused by aspirin or other nonsteroidal anti-inflammatory analgesics (including COX-2 inhibitors); for treatment of pain occurring before or after coronary artery bypass graft surgery; if you have genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption; if you are pregnant or may be pregnant or are breastfeeding; or if the patient is an infant 2 years old or younger. Before taking this medicine, consult a doctor or pharmacist if you may be pregnant, are a child, have a history of peptic ulcer, have a history of blood abnormalities, have a tendency to bleed, have hepatic impairment or a history thereof, have renal impairment or a history thereof, have reduced renal blood flow, cardiac dysfunction, hypertension, bronchial asthma, systemic lupus erythematosus or mixed connective tissue disease, or are elderly.
Show the Korean original
이 약에 과민증, 소화성궤양, 심한 혈액이상, 심한 간장애, 심한 심기능부전, 심한 신장애, 심한 고혈압, 아스피린 등 비스테로이드성 소염진통제에 과민증 환자, 아스피린이나 다른 비스테로이드성 소염진통제(COX-2 저해제 포함)에 의하여 천식, 비염(코염), 코의 용종, 두드러기, 알레르기 반응 또는 경험자, 관상동맥(심장동맥) 우회로술 전후에 발생하는 통증 치료, 갈락토오스 불내성, Lapp 유당분해효소 결핍증 또는 포도당-갈락토오스 흡수장애 등의 유전적인 문제가 있는 환자, 임부 또는 임신하고 있을 가능성이 있는 여성 및 수유부, 2세 이하의 영아(젖먹이)는 이 약을 복용하지 마십시오. 이 약을 복용하기 전에 임신하고 있을 가능성이 있는 여성, 소아, 소화성궤양 경험자, 혈액이상 경험자, 출혈경향이 있는 환자, 간장애 또는 경험자, 신장애 또는 경험자, 신혈류량 저하, 심기능 장애, 고혈압, 기관지천식, 전신성홍반성루푸스 및 혼합결합조직질환 환자, 고령자는 의사 또는 약사와 상의하십시오.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Napnopen Tablet, 10 Tablets Interactions
Do not take this medicine together with other nonsteroidal anti-inflammatory analgesics, naproxen derivatives, or high-dose methotrexate. Consult a doctor or pharmacist if taking it together with hydantoin antiepileptics, sulfonamides, sulfonylurea hypoglycemic agents, propranolol and other beta-blockers, ACE inhibitors (such as captopril), loop diuretics and thiazide diuretics, probenecid, aspirin, lithium, low-dose methotrexate, coumarin anticoagulants (such as warfarin), zidovudine, or new quinolone antibiotics (such as enoxacin).
Show the Korean original
다른 비스테로이드성 소염진통제, 나프록센 유도체, 고용량의 메토트렉세이트와 함께 복용하지 마십시오. 히단토인계 항간질제, 설파제, 설포닐요소계 혈당강하제, 프로프라놀롤 및 다른 -차단제, ACE억제제(캅토프릴 등), 루프계 이뇨제 및 티아지드계 이뇨제, 프로베네시드, 아스피린, 리튬, 저용량의 메토트렉세이트, 쿠마린계 혈액응고저지제(와파린 등), 지도부딘, 뉴퀴놀론계 항생물질(에녹사신 등)과 함께 복용 시 의사 또는 약사와 상의하십시오.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Napnopen Tablet, 10 Tablets Side effects
If shock symptoms (difficulty breathing, decreased blood pressure, slow pulse, cold sweat, swelling), PIE syndrome (pulmonary infiltration with eosinophilia: accompanied by fever, wheezing, cough, and sputum), urticaria, occasional hypersensitivity symptoms such as rash and itching, vomiting blood, gastrointestinal bleeding, peptic ulcer, perforation, agranulocytosis, eosinophilia, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, decreased platelet function (prolonged bleeding time), aseptic meningitis (severe headache, nausea, vomiting, insomnia, stiff neck, fever, or impaired consciousness, etc.), eczema, sweating, purpura, photosensitivity, hair loss, redness, necrolysis, erythema multiforme, oculomucocutaneous syndrome (Stevens-Johnson syndrome), urticaria, epidermolysis bullosa, drug reaction with eosinophilia and systemic symptoms, fixed drug eruption, toxic epidermal necrolysis, etc. occur rarely, stop taking this medicine immediately and consult a doctor or pharmacist. Stomach discomfort, stomach pain, abdominal pain, nausea, vomiting, loss of appetite, dyspepsia, heartburn, diarrhea, constipation, stomatitis may occur occasionally; abdominal bloating, black stools, dry mouth, elevation of GOT and GPT levels, jaundice, hepatitis, renal impairment, nephritis, hematuria, hyperkalemia, interstitial nephritis, nephrotic syndrome, renal papillary necrosis, protein in the urine, renal failure may occur rarely; drowsiness and cognitive dysfunction may occur occasionally; and dizziness, headache, numbness in the hands and feet, decreased potency, fatigue, depression, abnormal dreams, loss of ability to concentrate, disorientation, insomnia, muscle pain, muscle weakness, tinnitus, hearing impairment, visual impairment, swelling, difficulty breathing, palpitations, myasthenia, congestive heart failure, eosinophilic pneumonia, anaphylactoid reaction, menstrual disorder, chills (feeling cold and shivering) and fever, vasculitis, hyperglycemia, hypoglycemia, etc. may occur rarely.
Show the Korean original
드물게 쇽 증상(호흡곤란, 혈압강하, 느린 맥, 식은땀, 부기), PIE증후군(호산구증가를 수반하는 폐침윤: 발열, 숨을 쌕쌕거림, 기침, 가래를 동반함), 두드러기, 때때로 발진, 가려움 등의 과민증상, 혈액구토, 위장출혈, 소화성궤양, 뚫림, 무과립구증, 호산구증가, 백혈구감소, 혈소판감소, 재생불량성빈혈, 적혈구파괴성빈혈, 혈소판기능저하(출혈시간의 연장), 무균성 수막염(심한 두통, 구역, 구토, 불면, 목이 뻣뻣함, 발열 또는 의식장애 등), 습진, 땀이 남, 자주색 반점, 광과민증, 탈모, 발적(충혈되어 붉어짐), 괴사성용해, 여러 모양의 붉은 반점, 피부점막안증후군(스티븐스-존슨증후군), 두드러기, 표피 수포증, 호산구 증가 및 전신 증상 동반 약물 반응, 고정약물발진, 독성 표피괴사 등이 나타나는 경우 복용을 즉각 중지하고 의사 또는 약사와 상의하십시오. 때때로 위부불쾌감, 위통, 복통, 구역, 구토, 식욕부진, 소화불량, 가슴쓰림, 설사, 변비, 입안염, 드물게 복부팽만감, 흑변, 구갈, GOT, GPT 수치의 상승, 황달, 간염, 신장애, 신장염, 혈뇨, 고칼륨 혈증, 간질성 신염, 신증후군, 콩팥 유두괴사, 단백질이 섞인 오줌, 신부전, 때때로 졸음, 인식기능장애, 드물게 어지러움, 두통, 수족저림, 정력감퇴, 피로, 우울, 비정상적인 꿈, 집중능력 상실, 방향감각장애, 불면, 근육통, 근쇠약, 귀울림, 청각장애, 시각장애, 부기, 호흡곤란, 두근거림, 근육무력증, 울혈성심부전, 호산구성 폐렴, 아나필락시양 반응, 월경장애, 오한(춥고 떨리는 증상)과 발열, 혈관염, 고혈당, 저혈당 등이 나타날 수 있습니다.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Napnopen Tablet, 10 Tablets How to store it
Store at room temperature. Keep out of reach of children.
Show the Korean original
실온에서 보관하십시오. 어린이의 손이 닿지 않는 곳에 보관하십시오.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Pharmacy prices
₩900
Updated 2 months ago
See every reported price
Sign in to see the price at every pharmacy that reported one.
Sign in or sign up